Highlights: ● Compass employees in its Business and Industry division in the United Kingdom will take part in the ilumen™ well-being pilot commencing in July. ● ilumen™ will provide participants with access to a mobile and web application for [...]

Highlights: ● This study demonstrates that changes in heart rate across sleep-wake states may be valid physiological markers for the identification of depression in a sample of people with sleep complaints. ● The heart rate profiling algorithm classified individuals [...]

Medibio Announces Regulatory and Commercialisation Strategy Update Melbourne, Australia and Minneapolis, MN – 30 April 2019: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company provides the following update on regulatory strategy. Effective 29 April, [...]

Melbourne, Australia and Minneapolis, MN – 17 April 2019: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company today announces a Sponsored Research Agreement with the Department of Biomedical Sciences of Humanitas University, Milan, Italy. [...]

Sydney, Australia and Minneapolis, MN USA – 27 November 2018: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company announces that it has signed an exclusive agreement with AIAA to undertake a pilot program for [...]

Medibio Appoints Global Healthcare & Medical Device Leader as CEO and Managing Director   Sydney, Australia and Minneapolis, MN USA – 2 November 2018: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, announces the [...]

Sydney, Australia and Minneapolis, MN USA – 3 October 2018: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, today announced the release of ilumen™, its product and platform for corporate customers. ilumen™ is a [...]